-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES FREENOME’S SIMPLESCREEN™ CRC BLOOD-BASED SCREENING TEST; ABBOTT TO COMMERCIALIZE IN THE U.S.

Reuters·07/27/2026 12:00:04

Please log in to view news